Showing 2281-2290 of 5696 results for "".
- TearRestore Announces First of Its Kind Dry Eye Solutions; Now Available at Walmarthttps://modernod.com/news/tearrestore-announces-first-of-its-kind-dry-eye-solutions-now-available-at-walmart/2481643/TearRestore announced that its Thermal Mask and Eyelid Wipes will now be available at participating Walmart stores nationwide and at Walmart.com. Both products will be available for recommendation for dry eye by Walmart’s in-store optometrists. &ldqu
- AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseaseshttps://modernod.com/news/ai-used-to-advance-drug-delivery-system-for-glaucoma-and-other-chronic-diseases/2481636/Researchers from Wilmer Eye Institute, Johns Hopkins Medicine say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal e
- Norlase Secures $11M in New Funding Following Regulatory Clearance of ECHO Pattern Laserhttps://modernod.com/news/norlase-secures-11m-in-new-funding-following-regulatory-clearance-of-echo-pattern-laser/2481634/Norlase announced it has secured $11 million in funding, its largest investment round thus far. Norlase said the funding will enable it to accelerate the production ramp-up of the ECHO pattern laser, which just received FDA clearance and CE Mark earlier this month, as well as
- Research: Protein Deletion Could Treat Age and Diabetes-Induced Eye Diseaseshttps://modernod.com/news/research-protein-deletion-could-treat-age-and-diabetes-induced-eye-diseases/2481627/Researchers at the Wayne State University School of Medicine in Detroit say they have provided evidence that depletion of a certain protein in the body can treat age and diabetes-induced retinal diseases, according to a university news release. The protein, called vascular cell ad
- Precision Eye Therapy for Dogs Ready for Human Clinical Developmenthttps://modernod.com/news/precision-eye-therapy-for-dogs-ready-for-human-clinical-development/2481576/A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with retinitis pigmentosa, according to a university news release. Simon Petersen-Jones, professor and Donald R. Myers and Wil
- Registration Now Open for Neuro-Optometric Rehabiliation Association 2023 Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabiliation-association-2023-conference/2481568/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) 33rd annual conference, October 5-8, at the Portland Marriot Downtown Waterfront in Portland, Oregon. The NORA annual conference is an event for eye care and other health care
- Ciliatech Raises Money to Advance Development of Disruptive Glaucoma Implanthttps://modernod.com/news/ciliatech-raises-money-to-advance-development-of-disruptive-glaucoma-implant/2481560/Ciliatech announced it has raised €3.5M (about $4 million) to advance the company's glaucoma implant, CID (Cilio-scleral Inter-positioning Device), a technology that aims to disrupt traditional approaches in glaucoma surgery. Ciliatech says CID differs from other glau
- New Trefoil Therapeutics’ Data Presented at ARVO Demonstrate that TTHX1114 Controls Edema in At-Risk Patients Undergoing Cataract Surgeryhttps://modernod.com/news/new-trefoil-therapeutics-data-presented-at-arvo-demonstrate-that-tthx1114-controls-edema-in-at-risk-patients-undergoing-cataract-surgery/2481556/Trefoil Therapeutics announced a series of data presentations demonstrating the potential use of TTHX1114 to protect endothelial cells at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in New Orleans. The company also announced the completion of the phase 1 epithel
- Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic Systemhttps://modernod.com/news/bausch-lomb-announces-us-launch-of-stablevisc-cohesive-ophthalmic-viscosurgical-device-and-totalvisc-viscoelastic-system/2481555/Bausch + Lomb announced the US launch of StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. StableVis
- One Million Patients Measured on the Neurolens Measurement Devicehttps://modernod.com/news/one-million-patients-measured-on-the-neurolens-measurement-device/2481546/Neurolens announced that 1 million patients have been measured on the Neurolens Measurement Device, an eye tracking system that can identify eye misalignment as small as 0.01 prism diopters. Given the sharp acceleration in remote working and learning, optometrists have reported record number